Official vaccination schedule
The Government of La Rioja includes, from today, July 1, changes to the lifelong immunization programas the adviser said this Monday Health and social policyMaria Martin, together with the general director Public Health, Consumption and CareEva Martinez. The main innovations of this immunization program are related to inclusion of rotavirus vaccination at 2 and 4 months of age. And expansion of meningococcal ACWY vaccination at 4 months of age.
La Rioja acquired a total of 27,500 doses face a new version of the vaccination program for an amount that amounts to 1.6 million euros. Specific, 5000 doses for the amount 249,600 euros provide free vaccination against rotavirus to children aged 2 and 4 months.
On the other hand, it has acquired 8000 doses value 181,958.40 euros for meningococcal ACWY vaccine for infants aged 4 months, 12 months and children up to 12 years. In addition to the total 7500 doses value 309,192 euros for vaccine against pneumococcus serotype 15. And finally, 875,420 euros for purchase more than 7000 doses herpes zoster vaccines.
Moreover, as part of this new vaccination campaign, the Government of La Rioja will continue the immunizations and vaccinations started in 2023, among which immunization against RSV children under 6 months of age are vaccinated against influenza in minors and vaccination against Herpes zoster when you turn 80.
The Minister of Health and Social Policy stressed that this calendar “is a fundamental tool to guarantee the protection of citizens who, from childhood to adulthood, must receive these vaccines to help combat certain infectious diseases for which there are vaccines that can be administered safely and effectively.” Martin stressed that the implementation of these vaccination programs “means effective control of infectious diseases in children and in the most vulnerable groups of the population,” and stressed that, thanks to the new program, progress has been made “in the quality and equity of the vaccines supplied to La Rioja. In addition, he stressed that “a high percentage of people adhere to this program, achieving a vaccination coverage of more than 95% in many established guidelines, especially in the pediatric age group,” he said.
Immunization with respiratory syncytial virus (RSV) in children under 6 months of age.
The Autonomous Community of La Rioja has included in its 2023 immunization calendar the administration of nirsevimab during the respiratory syncytial virus (RSV) season to children under 6 months of age. Infections caused by this type of virus pose a significant health burden each winter. In addition, RSV infection is associated with a higher incidence of bacterial respiratory diseases.
For this reason, in July 2023, the Public Health Commission gave consent for the use of nirsevimab in the 2023-2024 season. in children under 6 months of age (at the beginning or during the RSV season). Nirsevimab immunization coverage in communities in the 2023–2024 season. was high, averaging more than 90% among those born during the season and 87% among those born before the season began. La Rioja achieved coverage of 92.5% and 92% respectively. In addition, it demonstrates a good safety profile, and epidemiological surveillance of RSV this season indicates a significant decrease in hospitalizations for RSV in children under one year of age compared to the 2022-2023 season.
Shingles Vaccination at Age 80
Likewise, in March 2023, systematic vaccination against herpes zoster was included in La Rioja among the entire population in the age group of 65 years. It started with those born in 1958. In addition, in order to cover a larger population, in the same year the population who turned 80 years old in 2023 (the 1943 cohort) began to be vaccinated and left to continue sequentially with the population cohorts that reached this age. During 2024, this would correspond to those born in 1944 turning 80 and those born in 1959 turning 65.
Vaccination schedule 2024
Pregnancy:
One dose of diphtheria-tetanus-pertussis vaccine is given at each pregnancy, starting at the 27th week of pregnancy, preferably at the 27th or 28th week.
Flu vaccine during the annual campaign.
0 months
Respiratory syncytial virus.
2 months:
Hexavalent vaccine (poliomyelitis, diphtheria, tetanus, whooping cough, hemophilus influenzae infection b, hepatitis B). Vaccine against meningococcus B, pneumococcus, rotavirus and respiratory syncytial virus.
4 months:
Hexavalent vaccine (poliomyelitis, diphtheria, tetanus, whooping cough, hemophilus influenzae b, Hepatitis B). Vaccine against pneumococcus, meningococcus B, meningococcus ACWY, rotavirus and respiratory syncytial virus.
From 6 to 59 months:
Flu vaccine in the annual campaign.
11 months:
Hexavalent vaccine (polio, diphtheria, tetanus, whooping cough, hemophilus influenzae b, hepatitis B). Pneumococcal vaccine.
12 months:
Vaccine against measles, rubella, mumps. Vaccine against meningococcus ACWY. Vaccine against meningococcus B.
15 months:
Chickenpox vaccine.
3 years:
Vaccine against measles, rubella, mumps and chickenpox.
6-7 years (1st primary education):
Vaccine against polio, diphtheria, tetanus, whooping cough.
11-12 years (6th primary education):
Human papillomavirus vaccine (boys and girls). Chickenpox. Meningococcus ACWY.
13-14 years (2nd ESO):
Diphtheria and tetanus vaccine.
15-59 years:
Adjusted vaccination recommendations will apply.
Over 60/64 years old:
Adjustment recommendations are based on year of birth, vaccination history, or infection history. Annual influenza.
65 years old:
Vaccine against diphtheria and tetanus. Vaccine against herpes zoster virus. Pneumococcal vaccine. Annual flu.
